DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) ( DrugBank: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
46
悪性関節リウマチ
1
46. 悪性関節リウマチ
臨床試験数
:
4,356
/
薬物数
:
2,567
- (
DrugBank
:
415
) /
標的遺伝子数
:
192
-
標的パスウェイ数
:
228
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2014-001299-79-DK
(
EUCTR
)
06/10/2014
07/07/2014
Pnemococcal vaccination of rheumatoid arthritis patients in biological treatment
Pneumococcal vaccination of rheumatoid arthritis patients in immunomodulatory therapy - Immunovax_RA
Pneumococcal vaccination of rheumatoid arthritis patients in immunomodulatory therapy - Immunovax_RA ...
Immunoresponse on pneumococcal vaccination of rheumatoid arthritis patients in immunomodulatory therapy
MedDRA version: 18.0;Level: LLT;Classification code 10069594;Term: Pneumococcal immunization;System Organ Class: 100000004865;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
Immunoresponse on pneumococcal vaccination of rheumatoid arthritis patients in immunomodulatory ther ...
Trade Name: Prevenar 13
INN or Proposed INN: pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
Other descriptive name: PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE
Trade Name: Pneumovax
INN or Proposed INN: pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F
Other descriptive name:
PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)
Trade Name: Prevenar 13
INN or Proposed INN: pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, ...
Department of Infectious Diseases, Odense University Hospital
NULL
Not Recruiting
Female: yes
Male: yes
Phase 3
Denmark